{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:38:22Z","timestamp":1793608702545,"version":"4.5.0"},"reference-count":76,"publisher":"American Society for Clinical Investigation","issue":"5","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["FDN 143251"],"award-info":[{"award-number":["FDN 143251"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Women and Children\u2019s Health Research Institute","award":["WCHRIIG 2874"],"award-info":[{"award-number":["WCHRIIG 2874"]}]},{"name":"The Friends of Garrett Cumming Research & Muscular Dystrophy Canada HM Toupin Neurological Science Research Chair","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"SMA Slipchuk Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,8]]},"abstract":"<jats:p>Antisense oligonucleotide\u2013mediated (AO-mediated) therapy is a promising strategy to treat several neurological diseases, including spinal muscular atrophy (SMA). However, limited delivery to the CNS with AOs administered intravenously or subcutaneously is a major challenge. Here, we demonstrate a single subcutaneous administration of cell-penetrating peptide DG9 conjugated to an AO called phosphorodiamidate morpholino oligomer (PMO) reached the CNS and significantly prolonged the median survival compared with unconjugated PMO and R6G-PMO in a severe SMA mouse model. Treated mice exhibited substantially higher expression of full-length survival of motor neuron 2 in both the CNS and systemic tissues compared with nontreated and unmodified AO\u2013treated mice. The treatment ameliorated the atrophic musculature and improved breathing function accompanied by improved muscle strength and innervation at the neuromuscular junction with no signs of apparent toxicity. We also demonstrated DG9-conjugated PMO localized in nuclei in the spinal cord and brain after subcutaneous injections. Our data identify DG9 peptide conjugation as a powerful way to improve the efficacy of AO-mediated splice modulation. Finally, DG9-PMO is a promising therapeutic option to treat SMA and other neurological diseases, overcoming the necessity for intrathecal injections and treating body-wide tissues without apparent toxicity.<\/jats:p>","DOI":"10.1172\/jci.insight.160516","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T12:01:08Z","timestamp":1675166468000},"source":"Crossref","is-referenced-by-count":20,"title":["DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration"],"prefix":"10.1172","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-6915","authenticated-orcid":true,"given":"Tejal","family":"Aslesh","sequence":"first","affiliation":[{"name":"Neuroscience and Mental Health Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2027-8344","authenticated-orcid":true,"given":"Esra","family":"Erkut","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[{"name":"Neuroscience and Mental Health Institute,"},{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-4183","authenticated-orcid":true,"given":"Kenji Rowel Q.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-3499","authenticated-orcid":true,"given":"Stanley","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hatlevig","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong M.","family":"Moulton","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gosgnach","sequence":"additional","affiliation":[{"name":"Neuroscience and Mental Health Institute,"},{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Greer","sequence":"additional","affiliation":[{"name":"Neuroscience and Mental Health Institute,"},{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5656-6930","authenticated-orcid":true,"given":"Rika","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[{"name":"Neuroscience and Mental Health Institute,"},{"name":"Department of Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60921-6"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-71"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.7.1177"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.18.9920"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature02919"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070399"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.4.1333-1346.2006"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121658"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2020.61.4.273"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6307"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1086\/513886"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2008.01.014"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.11.002"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2174\/1566524016666161128113338"},{"issue":"4","key":"B16","first-page":"801","article-title":"Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice","volume":"26","author":"Deguise","year":"2017","journal-title":"Hum Mol Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.057950"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq300"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq330"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.74"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01162-5"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00741"},{"issue":"2","key":"B23","doi-asserted-by":"crossref","DOI":"10.52965\/001c.25579","article-title":"Risdiplam for the use of spinal muscular atrophy","volume":"13","author":"Kakazu","year":"2021","journal-title":"Orthop Rev (Pavia)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2008.02414.x"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0883073815627882"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2021.02.007"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa126"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1220"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.06.036"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2016.0652"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605731113"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm418"},{"issue":"4\u20135","key":"B33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.addr.2007.09.002","article-title":"Cell penetrating peptide conjugates of steric block oligonucleotides","volume":"60","author":"Lebleu","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8651-4_18"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nm1385"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1112561108"},{"key":"B37","unstructured":"PepGen. Empowering Oligonucleotide Therapeutics. https:\/\/investors.pepgen.com\/static-files\/7244e66d-1227-42b1-841f-bf95306d84b1 Accessed February 2, 2023"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01274-0"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/71709"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.11.090"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.02.004"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.1996.0010"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurx.2006.01.010"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn156"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.1065874"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81251-9"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158015"},{"issue":"1\u20132","key":"B48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:30:1:223","article-title":"MuSK signaling at the neuromuscular junction","volume":"30","author":"Wang","year":"2006","journal-title":"J Mol Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2010.07569.x"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-016-9937-7"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2014.0528"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.01.008"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2018.0747"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112546119"},{"issue":"3","key":"B55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ymthe.2021.11.012","article-title":"Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model","volume":"30","author":"Bersani","year":"2021","journal-title":"Mol Ther"},{"issue":"20","key":"B56","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1093\/nar\/gkn671","article-title":"Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle","volume":"36","author":"Ivanova","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"7367","key":"B57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"issue":"3","key":"B58","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI131989","article-title":"Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models","volume":"130","author":"Kim","year":"2020","journal-title":"J Clin Invest"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2174\/138161205774580796"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X11311020006"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2010.02.012"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm478"},{"key":"B63","unstructured":"Sarepta Therapeutics. Sarepta Therapeutics Announces That FDA has Lifted its Clinical Hold on SRP-5051 for the Treatment of Duchenne Muscular Dystrophy. https:\/\/investorrelations.sarepta.com\/news-releases\/news-release-details\/sarepta-therapeutics-announces-fda-has-lifted-its-clinical-hold Updated September 6, 2022. Accessed February 22, 2023"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(02)00142-X"},{"issue":"12","key":"B65","first-page":"6045","article-title":"Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates","volume":"47","author":"Ostergaard","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2019.0794"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.02.009"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.09.011"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1613203114"},{"issue":"2","key":"B70","article-title":"Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 mice","volume":"4","author":"Echigoya","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"B71","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J Clin Invest"},{"key":"B72","unstructured":"El-Khodor BF. Behavioral Phenotyping for Neonates: Hind Limb Suspension Test (a.k.a. Tube Test). https:\/\/treat-nmd.org\/downloads\/file\/sops\/sma\/SMA_M.2.2.001.pdf Updated March 14, 2011. Accessed February 22, 2023"},{"key":"B73","unstructured":"Corti SP. Grip Strength. https:\/\/treat-nmd.org\/wp-content\/uploads\/2016\/08\/sma-SMA_M.2.1.002.pdf Updated July 11, 2017. Accessed February 22, 2023"},{"issue":"14","key":"B74","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1093\/nar\/gkz469","article-title":"Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA","volume":"47","author":"Donadon","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31819faa2a"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000490"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/160516\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:57:56Z","timestamp":1779141476000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/160516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":76,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3,8]]},"published-print":{"date-parts":[[2023,3,8]]}},"alternative-id":["10.1172\/jci.insight.160516"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.160516","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"e160516"}}